Menu
ÚHKT

Impaktované publikace

[1]

Kuželová, K.; Brodská, B.; Marková, J.; Petráčková, M.; Schetelig, J.; Ransdorfová, Š.; Gašová, Z.; Šálek, C.

NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia

[rok vydání 2022, impact factor 8.110 ]

[2]

Podrazil, M.; Horvath, R.; Becht, E.; Rozkova, D.; Bilkova, P.; Sochorova, K.; Hromadkova, H.; Kayserova, J.; Vavrova, K.; Lastovicka, J.; Vrabcova, P.; Kubackova, K.; Gasova, Z.; Jarolim, L.; Babjuk, M.; Spisek, R.; Bartunkova, J.; Fucikova, J.

Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer

[rok vydání 2015, impact factor 5.008]

[3]

Brodská, B.; Otevřelová, P.; Šálek, C.; Fuchs, O.; Gašová, Z.; Kuželová, K.

High PD-L1 expression predicts for worse outcome of leukemia patients with concomitant NPM1 and FLT3 mutations

[rok vydání 2019, impact factor 4.556 ]

[4]

Stegmayr, B.; Newman, E.; Witt, V.; Derfler, K.; Leitner, G.; Eloot, S.; Dhondt, A.; Deeren, D.; Ptak, J.; Blaha, M.; Lanska, M.; Gasova, Z.; Bhuiyan-Ludvikova, Z.; et al.

Using the World Apheresis Association registry helps to improve the treatment quality of therapeutic apheresis

[rok vydání 2021, impact factor 3.747 ]

[5]

Spisek, R.; Gasova, Z.; Bartunkova, J.

Maturation state of dendritic cells during the exctracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host disease.

[rok vydání 2006, impact factor 3.278]

[6]

Pecankova, K.; Pecherkova, P.; Gasova, Z.; Sovova, Z.; Riedel, T.; Jäger, E.; Cermak, J.; Majek, P.

Proteome changes of plasma-derived extracellular vesicles in patients with myelodysplastic syndrome

[rok vydání 2022, impact factor 3.240 ]

[7]

Kuželová, K.; Obr, A.; Marková, J.; Gašová, Z.

Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: impact of NPM1 and FLT3 mutations

[rok vydání 2020, impact factor 2.997 ]

[8]

Klener, P.Jr.; Leahomschi, S.; Molinsky, J.; Simonova, T.; Necas, E.; Gasova, Z.; Cermak, J.; Dolezalova, L.; Andera, L.; Zivny, J.

TRAIL-induced apoptosis of HL60 leukemia cells : two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine

[rok vydání 2008, impact factor 2.901]

[9]

Molinsky, J.; Klanova, M.; Koc, M.; Beranova, L.; Andera, L.; Ludvikova, Z.; Bohmova, M.; Gasova, Z.; Strnad, M.; Ivanek, R.; Trneny, M.; Necas, E.; Zivny, J.; Klener, P.

Roscovitine sensitizes leukemia and lymphoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

[rok vydání 2013, impact factor 2.605 ]

[10]

Majek, P.; Pecankova, K.; Cermak, J.; Gasova, Z.; Dyr, J.E.

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups

[rok vydání 2015, impact factor 2.401 ]

[11]

Majek, P.; Pecankova, K.; Cermak, J.; Gasova, Z.; Prochazka, B.; Dyr, J.E.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes

[rok vydání 2018, impact factor 2.392 ]

[12]

Moravcová, J.; Nádvorníková, S.; Zmeková, V.; Michalová, K.; Březinová, J.; Lukášová, M.; Vítek, A.; Hrabánek, J.; Gašová, Z.; Sedláček, P.; Starý, J.

Molecular monitoring of responses to DLI and DLI + IFN treatment of post-SCT relapses in patients with CML

[rok vydání 2006, impact factor 2.333]

[13]

Moravcová, J.; Muchová, S.; Lukášová, M.; Klamová, H.; Březinová, J.; Gašová, Z.

Late molecular relapse in two CML patients in molecular remission after donor lymphocyte transfusion for post-BMT relapse

[rok vydání 2006, impact factor 2.277]

[14]

Havlíček, J.; Gašová, Z.; Smith, A.P.; Zvára, K.; Flegr, J.

Decrease of psychomotor performance in subjects with latent "asymptomatic" toxoplasmosis

[rok vydání 2006, impact factor 2.114]

[15]

Novotna, M.; Havlicek, J.; Smith, A.P.; Kolbekova, P.; Skallova, A.; Klose, J.; Gasova, Z.; Pisacka, M.; Sechovska, M.; Flegr, J.

Toxoplasma and reaction time : role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism

[rok vydání 2008, impact factor 2.071]

[16]

Lysák, D.; Kořístek, Z.; Gašová, Z.; Skoumalová, I.; Jindra P.

Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?

[rok vydání 2011, impact factor 1.933]

[17]

Bartošová, J.; Kuželová, K.; Pluskalová, M.; Marinov, I.; Halada, P.; Gašová, Z.

UVA-activated 8-methoxypsoralen (PUVA) causes G2/M cell cycle arrest in Karpas 299 T-lymphoma cells

[rok vydání 2006, impact factor 1.909]

[18]

Blaha, M.; Gasova, Z.; Berlin, G.; Audzijoniene, J.; Griskevicius, A.; Dykes, J.; Bhuiyanova, Z.; et al.

Analysis of extracorporeal photopheresis within the frame of the WAA register

[rok vydání 2021, impact factor 1.764 ]

[19]

Stegmayr, B.; Mörtzell Henriksson, M.; Newman, E.; Witt, V.; Derfler, K.; Leitner, G.; Eloote, S.; Dhondte, A.; Deeren, D.; Rock, G.; Ptak, J.; Blaha, M.; Lanska, M.; Gasova, Z.; Bhuiyan-Ludvikova, Z.; et al.

Distribution of indications and procedures within the framework of centers participating in the WAA apheresis registry

[rok vydání 2017, impact factor 1.755 ]

[20]

Blaha, M.; Gasova, Z.

Advances in haemapheresis and haemotherapy.

[rok vydání 2006, impact factor 1.657]

Neimpaktované publikace

[1]

Gašová, Z.

Hemoterapie

[rok vydání 2007]